A comparison of kinetics of paraprotein clearance after infusional chemotherapy versus high-dose melphalan in previously untreated patients with IgG multiple myeloma.

被引:0
|
作者
Sirohi, B
Powles, R
Sumpter, K
Kulkarni, S
Singhal, S
Bhagwati, N
Horton, C
Saso, R
Mehta, J
Treleaven, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4631
引用
收藏
页码:314B / 314B
页数:1
相关论文
共 50 条
  • [1] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
    Nowrousian, MR
    Wrzeciono, T
    Tewes, M
    Fossa, A
    Welt, A
    Schuett, P
    Brandhorst, D
    Kloke, O
    Schuette, J
    Seeber, S
    BLOOD, 2000, 96 (11) : 421A - 421A
  • [2] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [3] High-dose sequential chemotherapy in the treatment of multiple myeloma.
    Canales, M
    Ojeda, E
    Jiménez, V
    Jiménez, MT
    Hernández, D
    Alvárez, MT
    Martín, MP
    Bustos, JG
    Aguado, MJ
    Navarro, FH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S205 - S205
  • [4] A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
    Gasparetto, C
    Keogh, GP
    Gockerman, JP
    Horwitz, M
    Moore, JO
    DeCastro, C
    Diehl, L
    Davis, P
    Chao, N
    Rizzieri, DA
    BLOOD, 2005, 106 (11) : 379B - 379B
  • [5] Outpatient high-dose melphalan in multiple myeloma patients
    Kassar, Mohamad
    Medoff, Erin
    Seropian, Stuart
    Cooper, Dennis L.
    TRANSFUSION, 2007, 47 (01) : 115 - 119
  • [6] Effect of Obesity and Renal Insufficiency On Toxicity of High-Dose Melphalan for Multiple Myeloma.
    Vogl, Dan T.
    Paul, Thomas M.
    Stoopler, Eric
    Salazar, Gentian
    Davis, Lisa
    Kapoor, Shiv
    Zemel, Babette
    Yudkoff, Mark
    Jackson, Gail
    Basel-Brown, Lisa
    Rockwell, Kenneth
    Daikhin, Evgueni
    Swider, Cezary R.
    Washington, John
    Raguza-Lopez, Maria
    Tenhave, Thomas
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 483 - 484
  • [7] Engraftment Kinetics after High-Dose Melphalan Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Bachier-Rodriguez, Lizamarie
    Shah, Gunjan L.
    Knezevic, Andrea
    Devlin, Sean M.
    Maloy, Molly
    Koehne, Guenther
    Chung, David J.
    Landau, Heather
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S142 - S143
  • [8] Neoplasias after high-dose melphalan for multiple myeloma (MM) patients (pts)
    da Costa, F. Leal
    Miranda, N.
    Coelho, J. L. Passos
    Guimaraes, A.
    Ferreira, I.
    Teixeira, G.
    Fernandez, E.
    Abecasis, M. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S443 - S443
  • [9] MULTIPLE-MYELOMA - COMPLETE REMISSION WITH HIGH-DOSE MELPHALAN CHEMOTHERAPY
    RICHARDS, F
    COLEMAN, M
    COOPER, MR
    BALLARD, WP
    CANCER INVESTIGATION, 1985, 3 (01) : 15 - 21
  • [10] Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma
    Gillich, Cedric
    Akhoundova, Dilara
    Hayoz, Michael
    Aebi, Yolanda
    Largiader, Carlo R.
    Seipel, Katja
    Daskalakis, Michael
    Bacher, Ulrike
    Pabst, Thomas
    CANCERS, 2023, 15 (10)